Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wen-Fang Xu
Using Caffeoyl Pyrrolidine Derivative LY52, a Potential Inhibitor of Matrix Metalloproteinase-2, to Suppress Tumor Invasion and Metastasis
International Journal of Molecular Medicine
Medicine
Genetics
Related publications
Stat3 Activation Regulates the Expression of Matrix Metalloproteinase-2 and Tumor Invasion and Metastasis
Oncogene
Cancer Research
Genetics
Molecular Biology
Upregulated Matrix Metalloproteinase-2 and Downregulated Tissue Factor Pathway Inhibitor-2 Are Risk Factors for Lymph Node Metastasis and Perineural Invasion in Pancreatic Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
MicroRNA-106a Promotes Cell Migration and Invasion by Targeting Tissue Inhibitor of Matrix Metalloproteinase 2 in Cervical Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Helicobacter Pylori Infection Promotes the Invasion and Metastasis of Gastric Cancer Through Increasing the Expression of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-10
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Contribution of Matrix Metalloproteinase-2 Promoter Genotypes to Nasopharyngeal Cancer Susceptibility and Metastasis in Taiwan
Cancer Genomics and Proteomics
Medicine
Biochemistry
Genetics
Molecular Biology
Cancer Research
Cannabinoid WIN-55,212-2 Mesylate Inhibits Interleukin-1β Induced Matrix Metalloproteinase and Tissue Inhibitor of Matrix Metalloproteinase Expression in Human Chondrocytes
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Imbalance Between Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinases 1 Expression by Tumor Cells Implicated in Liver Metastasis From Colorectal Carcinoma.
Kurume Medical Journal
Medicine
Microtubule-Dependent Matrix Metalloproteinase-2/Matrix Metalloproteinase-9 Exocytosis
Cancer Research
Cancer Research
Oncology
Matrix Metalloproteinase‑2 and ‑9 and Tissue Inhibitor of Metalloproteinase‑1 and ‑2 in Sera and Urine of Patients With Renal Carcinoma
Oncology Letters
Cancer Research
Oncology